These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 2241996

  • 1. Chemical modification reveals involvement of tyrosine in ligand binding to dopamine D1 and D2 receptors.
    Srivastava LK, Mishra RK.
    Biochem Int; 1990; 21(4):705-14. PubMed ID: 2241996
    [Abstract] [Full Text] [Related]

  • 2. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
    Hilakivi I, Rinne J, Marjamäki P.
    Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
    [Abstract] [Full Text] [Related]

  • 3. Expression of the bovine striatal D2 receptor, but not the D1 receptor, in bovine adrenal medulla.
    Maroto R, López MG, del Valle M, Naranjo JR, Mellström B, García AG.
    Mol Pharmacol; 1995 Jan; 47(1):40-50. PubMed ID: 7838132
    [Abstract] [Full Text] [Related]

  • 4. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA, Marsh CL.
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [Abstract] [Full Text] [Related]

  • 5. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
    Rubinstein M, Muschietti JP, Gershanik O, Flawia MM, Stefano FJ.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
    [Abstract] [Full Text] [Related]

  • 6. Cerebellar and striatal dopamine receptors: effects of reeler and weaver murine mutations.
    Panagopoulos NT, Matsokis NA, Valcana T.
    J Neurosci Res; 1993 Aug 01; 35(5):499-506. PubMed ID: 8377223
    [Abstract] [Full Text] [Related]

  • 7. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
    Joyce JN, Lexow N, Bird E, Winokur A.
    Synapse; 1988 Aug 01; 2(5):546-57. PubMed ID: 2973147
    [Abstract] [Full Text] [Related]

  • 8. Inactivation of D1 and D2 dopamine receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo: selective protection by neuroleptics.
    Meller E, Bohmaker K, Goldstein M, Friedhoff AJ.
    J Pharmacol Exp Ther; 1985 Jun 01; 233(3):656-62. PubMed ID: 2861276
    [Abstract] [Full Text] [Related]

  • 9. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW, Creese I.
    Mol Pharmacol; 1982 Jan 01; 21(1):44-51. PubMed ID: 6127621
    [Abstract] [Full Text] [Related]

  • 10. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK, Scott CE, Vazquez DM, Bhatnagar RK.
    Mol Pharmacol; 1988 Apr 01; 33(4):402-13. PubMed ID: 3357484
    [Abstract] [Full Text] [Related]

  • 11. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH, Gnegy ME.
    Mol Pharmacol; 1989 Jan 01; 35(1):139-47. PubMed ID: 2563306
    [Abstract] [Full Text] [Related]

  • 12. Impaired ontogeny of striatal dopamine D1 and D2 binding sites after postnatal treatment of rats with SCH-23390 and spiroperidol.
    Kostrzewa RM, Saleh MI.
    Brain Res Dev Brain Res; 1989 Jan 01; 45(1):95-101. PubMed ID: 2645067
    [Abstract] [Full Text] [Related]

  • 13. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner.
    Nakajima T, Iwata K.
    Mol Pharmacol; 1984 Nov 01; 26(3):430-8. PubMed ID: 6149457
    [Abstract] [Full Text] [Related]

  • 14. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U, Tränkle C, Mohr K, Gmeiner P.
    Pharmazie; 1999 Apr 01; 54(4):294-7. PubMed ID: 10234741
    [Abstract] [Full Text] [Related]

  • 15. Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography.
    Beckstead RM, Wooten GF, Trugman JM.
    J Comp Neurol; 1988 Feb 01; 268(1):131-45. PubMed ID: 2964456
    [Abstract] [Full Text] [Related]

  • 16. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors.
    Seeman P, Sunahara RK, Niznik HB.
    Synapse; 1994 May 01; 17(1):62-4. PubMed ID: 8042146
    [Abstract] [Full Text] [Related]

  • 17. Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor.
    Leff SE, Creese I.
    Mol Pharmacol; 1985 Feb 01; 27(2):184-92. PubMed ID: 3969067
    [Abstract] [Full Text] [Related]

  • 18. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C, Ebadi M, Govitrapong P.
    J Pineal Res; 2005 Apr 01; 38(3):170-5. PubMed ID: 15725338
    [Abstract] [Full Text] [Related]

  • 19. A photoaffinity ligand for dopamine D2 receptors: azidoclebopride.
    Niznik HB, Guan JH, Neumeyer JL, Seeman P.
    Mol Pharmacol; 1985 Feb 01; 27(2):193-9. PubMed ID: 3969068
    [Abstract] [Full Text] [Related]

  • 20. Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.
    McGonigle P, Boyson SJ, Reuter S, Molinoff PB.
    Synapse; 1989 Feb 01; 3(1):74-82. PubMed ID: 2521960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.